TMDX

85.04

1.57% -1.36

Dopo l'orario di chiusura: 84.50 -0.54 -0.63%

Transmedics Group Inc (TMDX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché TMDX Giù? Forum Previsione

Precedente Chiudi:

$86.40

Aprire:

$85.27

Volume 24 ore:

590.94K

Relative Volume:

0.64

Capitalizzazione di mercato:

$2.95B

Reddito:

$635.89M

Utile/perdita netta:

$171.92M

Rapporto P/E:

19.52

EPS:

4.357

Flusso di cassa netto:

$151.36M

1 W Prestazione:

-2.23%

1M Prestazione:

-3.81%

6M Prestazione:

-35.01%

1 anno Prestazione:

-21.11%

Intervallo 1D:

$83.69

$87.55

Intervallo di 1 settimana:

$83.61

$90.11

Portata 52W:

$60.10

$156.00

Transmedics Group Inc Stock (TMDX) Company Profile

Nome

Transmedics Group Inc

Settore

Healthcare (1069)

Industria

Medical Devices (140)

Telefono

(978) 552-0900

Indirizzo

200 MINUTEMAN ROAD, ANDOVER, MA

Dipendente

898

Cinguettio

@transmedics

Prossima data di guadagno

2026-11-04

Ultimi documenti SEC

TMDX's Discussions on Twitter

Compare TMDX vs ABT, MDT, SYK, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TMDX Transmedics Group Inc	85.04	3.00B	635.89M	171.92M	151.36M	4.357
ABT Abbott Laboratories	103.36	182.09B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	91.62	117.54B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	270.01	105.63B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	43.10	65.16B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.77	49.67B	6.30B	1.07B	1.09B	1.8406

Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-23	Aggiornamento	Needham	Hold → Buy
2025-10-13	Iniziato	Jefferies	Buy
2025-09-16	Iniziato	Evercore ISI	Outperform
2025-09-04	Iniziato	Stifel	Hold
2024-12-17	Downgrade	JP Morgan	Overweight → Neutral
2024-11-22	Downgrade	Needham	Buy → Hold
2024-10-29	Reiterato	Needham	Buy
2024-10-29	Reiterato	Oppenheimer	Outperform
2024-09-24	Iniziato	Robert W. Baird	Outperform
2024-08-21	Iniziato	Needham	Buy
2024-06-06	Iniziato	Cantor Fitzgerald	Overweight
2024-06-04	Iniziato	Stephens	Overweight
2024-03-28	Iniziato	Piper Sandler	Overweight
2023-07-19	Iniziato	Robert W. Baird	Outperform
2022-08-02	Aggiornamento	JP Morgan	Neutral → Overweight
2020-10-08	Downgrade	JP Morgan	Overweight → Neutral
2020-04-07	Iniziato	Oppenheimer	Outperform
2019-05-28	Iniziato	Canaccord Genuity	Buy
2019-05-28	Iniziato	Cowen	Outperform
2019-05-28	Iniziato	JP Morgan	Overweight
2019-05-28	Iniziato	Morgan Stanley	Equal-Weight

Mostra tutto

Transmedics Group Inc Borsa (TMDX) Ultime notizie

05:34 AM

TransMedics Appoints Fernando Araujo as CFO with Detailed Compensation and Transition Plan - Kalkine Media

05:34 AM

04:21 AM

TransMedics names Fernando Araujo as CFO, reaffirms 2026 outlook By Investing.com - Investing.com India

04:21 AM

04:20 AM

(TMDX) TransMedics Expects Full Year 2026 Revenue Range $737M$757M, vs. FactSet Est of $743.1M - marketscreener.com

04:20 AM

04:05 AM

TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook - PR Newswire

04:05 AM

01:01 AM

TransMedics Group (NASDAQ:TMDX): Is the Market Too Cautious? - Kalkine Media

01:01 AM

02:31 AM

TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

02:31 AM

Sep 09, 2026

NFLX: Netflix Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Sep 09, 2026

TransMedics: Slowing Growth Brings Its Valuation Into Question (NASDAQ:TMDX) - Seeking Alpha

Sep 08, 2026

Sep 07, 2026

Law firm probes TransMedics officers for possib... - Pluang

Sep 07, 2026

Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire

Sep 07, 2026